Surgical Resection Outcomes in Patients With Brain Metastasis
Prognostic Factors Impacting Surgical Resection Outcomes in Patients With Brain
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Jung-Shun Lee, M.D.
- Phone Number: 5181 886-6-2353535
- Email: nslee1218@gmail.com
Study Locations
-
-
None Selected
-
Tainan, None Selected, Taiwan, 70403
- Recruiting
- Jung-Shun Lee
-
Contact:
- Jung-Shun Lee, M.D.
- Phone Number: 5181 886-6-2353535
- Email: nslee1218@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients with Clinical diagnosis of brain metastasis
- patients who underwent craniotomy surgery for brain metastasis
Exclusion Criteria:
- patients with insufficient data for associated factors
- patients who underwent stereotactic biopsy for brain metastasis
- patients who did not undergo craniotomy surgery for brain metastasis
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
survival outcome of patients undergoing surgery for brain metastasis
Time Frame: From date of surgery until the date of death from any cause, whichever came first, assessed up to 100 months
|
overall survival of patients
|
From date of surgery until the date of death from any cause, whichever came first, assessed up to 100 months
|
|
Functional outcome of patients undergoing surgery for brain metastasis
Time Frame: from date of surgery until 6 months after surgery ordate of death from any cause, whichever came first
|
change of preoperative and postoperative modified rankin scale
|
from date of surgery until 6 months after surgery ordate of death from any cause, whichever came first
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Jung-Shun Lee, M.D., National Cheng Kung Univsersity Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- B-ER111-370
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.